734PImpact of dose reduction or dose delay on the efficacy of liposomal irinotecan (nal-IRI)+5-fluorouracil/leucovorin (5-FU/LV): Survival analysis from NAPOLI-1
Chen, L-T, Macarulla, T M, Blanc, J, Mirakhur, B, de Jong, F A, Belanger, B, Bekaii-Saab, T, Siveke, JVolume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy282.117
Date:
October, 2018
File:
PDF, 93 KB
english, 2018